Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-034653

Chief Operating Officer sold 20,000 shares at $12.00 ($240,000)

  • Chief Operating Officer gave up 15,215 shares (to pay taxes)
  • Chief Operating Officer acquired 60,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Capponi Vincent Chief Operating Officer 2018-06-14 Option exercise +11,367 $3.75 $42,626 319,350 D
Capponi Vincent Chief Operating Officer 2018-06-15 Option exercise +8,633 $3.75 $32,374 327,983 D
Capponi Vincent Chief Operating Officer 2018-06-15 Option exercise +40,000 $0.88 $35,000 367,983 D
Capponi Vincent Chief Operating Officer 2018-06-14 Sale −11,367 $12.00 $136,404 356,616 D
Capponi Vincent Chief Operating Officer 2018-06-15 Sale −8,633 $12.00 $103,596 347,983 D
Capponi Vincent Chief Operating Officer 2018-06-15 Shares withheld for taxes −15,215 $12.35 $187,905 332,768 D
Derivatives
Capponi Vincent Chief Operating Officer 2018-06-14 Option exercise · Stock Option (right to buy) −11,367 69,933 D
Capponi Vincent Chief Operating Officer 2018-06-15 Option exercise · Stock Option (Right to Buy) −8,633 61,300 D
Capponi Vincent Chief Operating Officer 2018-06-15 Option exercise · Stock Option (Right to Buy) −40,000 0 D
Open-market sales · 20,000 sh · avg $12.00 · $240,000
Loading xslF345X03/tv496714_4.xml…